Heart disease is more common in people over 65, but treatments are better than ever. That can complicate decision-making for older heart patients.
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
A team of researchers, led by one of Indian origin, has found that a drug recently approved by the US Food and Drug ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...
13h
WTAJ Altoona on MSNWhat to know about weight loss drugs to keep your heart healthyLosing weight can support better heart health, but now doctors are warning of their possible impacts on your heart. Ozempic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results